Mankind Pharma focuses on specialty business, expanding therapeutic segments and plugging gaps in competitive market.

These include Glenmark Pharmaceuticals’ Telma H, prescribed by doctors to manage blood pressure, and Sun Pharmaceutical ... As a result, over 300 actions like issuance of show-cause notices ...

Companies like Sun Pharma and Glenmark echoed similar sentiments, asserting they had no involvement in the production of the implicated medications. This scrutiny follows a recent ban on over 156 ...

Some of the drugs were commonly used, over-the-counter drugs like Paracetamol. As per reports, Sun Pharma’s Ursocol 300 was flagged as well. These drugs were deemed to have failed the quality ...

Sun Pharmaceutical Industries Limited including its subsidiaries ... It includes generics branded generics complex or difficult to make technology intensive products over-the-counter (OTC) products ...

These drugs are produced by several pharmaceutical companies. Some firms have denied responsibility, calling the products spurious. In August, the CDSCO banned over 156 fixed-dose combinations.

Companies like Sun Pharma and Glenmark echoed similar sentiments, asserting they had no involvement in the production of the implicated medications. This scrutiny follows a recent ban on over 156 ...

Mankind Pharma has executed a Business Transfer Agreement (BTA) to transfer its Over-the-Counter (OTC) business undertaking to its wholly owned subsidiary, Mankind Consumer Products Private ...

Sun Pharma is also in the business of producing Over-the-Counter (OTC) products. Some of the OTC products sold by Sun Pharma are analgesics, antacids, skincare products, etc. Listing Pharma major ...

Overall, pharma ... to show over 10% growth, partly due to its joint venture with Nestle. In the US market, pharma companies could grow by around 11% likely fueled by Sun Pharma’s strong speciality ...

With a strong presence in over 100 countries, Sun Pharma's products are globally recognised for their quality and innovation. The company is dedicated to enhancing healthcare by offering affordable ...

Natco Pharma rose as much as 4% in morning trading on October 7, following a settlement ruling in the United States patent litigation involving generic Ozempic products. The stock price surged ...